Epidemiological Surveillance of Clinical Bacterial Infections and Antimicrobial Resistance Management
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 June 2026 | Viewed by 19
Special Issue Editors
Interests: antimicrobial resistance; resistance mechanisms; molecular microbiology; antimicrobial activity; carbapenem resistance
Special Issues, Collections and Topics in MDPI journals
Interests: therapeutic drug monitoring; pharmacokinetics; drug–drug interaction; antimicrobial therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) has emerged as a global public health crisis, posing severe threats to the efficacy of clinical antimicrobial agents and the management of bacterial infections. The epidemiological surveillance of clinical bacterial infections—including the distribution of pathogenic bacteria, trends in infection prevalence, and their correlation with AMR—serves as the cornerstone for formulating targeted AMR control strategies.
This Special Issue in Pharmaceuticals aims to gather cutting-edge research, clinical evidence, and practical experiences focused on the intersection of epidemiological surveillance of clinical bacterial infections and AMR management. Topics of interest include, but are not limited to, the following: large-scale epidemiological investigations of drug-resistant bacterial infections (e.g., carbapenem-resistant Enterobacterales, methicillin-resistant Staphylococcus aureus); the development and application of rapid diagnostic tools for AMR surveillance; the impact of antimicrobial stewardship (AMS) programs on infection control and AMR trends; pharmacodynamic/pharmacokinetic (PK/PD) optimization of antimicrobial agents for drug-resistant infections; and the integration of multi-center surveillance data into AMR prevention policies. By synthesizing insights from microbiology, clinical pharmacy, epidemiology, and public health, this Special Issue seeks to provide a comprehensive platform for researchers, clinicians, and policymakers to share innovations, address key challenges, and advance evidence-based practices that mitigate the AMR burden and improve outcomes of clinical bacterial infection management.
Dr. Davide Carcione
Dr. Dario Cattaneo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- clinical bacterial infections
- epidemiological surveillance
- antimicrobial stewardship (AMS)
- drug-resistant pathogens
- rapid diagnostic tools for AMR
- pharmacokinetics/pharmacodynamics (PK/PD) of antimicrobials
- infection control
- multi-center surveillance data
- public health policy for AMR
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
